30% off. Use code at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

United States Pharmaceuticals

Track

Hims & Hers Health Inc (HIMS)

Track

Over the last 90 days, Hims & Hers Health Inc. has seen significant insider selling, with executives selling a net value of $830,410. Notable transactions include sales by the Chief Financial Officer and Chief Medical Officer. The company's stock has experienced a 58.0% increase in the last 90 days.

Top insider sells (30d)

Top executive sells (90, 60, 30d)

Featured in screeners

Top insider sells

Top executive sells

Stock chart

Ticker: HIMS Exchange: NYS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Search

Download results Settings

Trades

Okupe Oluyemi

Chief Financial Officer

1 sale — total 100,000 USD

Planned sale 22 Jun 2026

Value US$3,367,636.53 | Price 456.65 | Shares 64,878

Carroll Patrick Harrison

Chief Medical Officer

2 sales — total 200,000 USD

Sale 18 Jun 2026

Value US$4,686,049.80 | Price 334.02 | Shares 61,584

Proposed sale 18 Jun 2026

Value US$3,561,118.00 | Price 279.52 | Shares 74,926

Becklund Irene

PAO

2 sales — total 200,000 USD

Planned sale 17 Jun 2026

Value US$100,000.00 | Price 31.50 | Shares 1,000

Proposed sale 17 Jun 2026

Value US$100,000.00 | Price 31.50 | Shares 1,000

Chi Michael

Chief Operating Officer

2 sales — total 200,000 USD

Planned sale 17 Jun 2026

Value US$100,000.00 | Price 31.50 | Shares 1,000

Proposed sale 17 Jun 2026

Value US$100,000.00 | Price 31.50 | Shares 1,000

Elshenawy Mohamed

CTO

2 sales — total 200,000 USD

Planned sale 17 Jun 2026

Value US$100,000.00 | Price 31.50 | Shares 1,000

Proposed sale 17 Jun 2026

Value US$100,000.00 | Price 31.50 | Shares 1,000

Becklund Irene

PAO

2 sales — total 200,000 USD

Planned sale 16 Jun 2026

Value US$100,000.00 | Price 30.25 | Shares 1,000

Proposed sale 16 Jun 2026

Value US$100,000.00 | Price 30.25 | Shares 1,000

WELLS DAVID B

1 purchase — total 1,172,974 USD

Buy 26 May 2026

Value US$1,172,974.00 | Price 24.24 | Shares 48,400

Okupe Oluyemi

Chief Financial Officer

1 sale — total 187,916 USD

Planned sale 18 May 2026

Value US$187,915.74 | Price 23.64 | Shares 7,950

Boughton Soleil

Chief Legal Officer

2 sales — total 567,780 USD

Planned sale 20 Apr 2026

Value US$283,890.00 | Price 30.00 | Shares 9,463

Proposed sale 20 Apr 2026

Value US$283,890.00 | Price 30.00 | Shares 9,463

Okupe Oluyemi

Chief Financial Officer

1 sale — total 588,615 USD

Planned sale 20 Apr 2026

Value US$588,615.28 | Price 29.96 | Shares 19,645

Okupe Oluyemi

Chief Financial Officer

1 sale — total 501,158 USD

Planned sale 17 Apr 2026

Value US$501,158.37 | Price 27.83 | Shares 18,005

Okupe Oluyemi

Chief Financial Officer

1 sale — total 956,147 USD

Planned sale 16 Apr 2026

Value US$956,146.88 | Price 25.90 | Shares 36,922

Okupe Oluyemi

Chief Financial Officer

1 sale — total 79,409 USD

Planned sale 6 Apr 2026

Value US$79,408.58 | Price 19.98 | Shares 3,975

Oluyemi Okupe

Officer

1 sale — total 4,890,585 USD

Proposed sale 6 Apr 2026

Value US$4,890,584.80 | Price 20.33 | Shares 240,560

Okupe Oluyemi

Chief Financial Officer

1 sale — total 219,067 USD

Planned sale 20 Mar 2026

Value US$219,066.89 | Price 23.77 | Shares 9,217

Boughton Soleil

Chief Legal Officer

2 sales — total 237,617 USD

Planned sale 17 Mar 2026

Value US$118,808.28 | Price 24.69 | Shares 4,812

Proposed sale 17 Mar 2026

Value US$118,808.28 | Price 24.69 | Shares 4,812

Becklund Irene

PAO

2 sales — total 273,022 USD

Planned sale 17 Mar 2026

Value US$136,511.01 | Price 24.69 | Shares 5,529

Proposed sale 17 Mar 2026

Value US$136,511.01 | Price 24.69 | Shares 5,529

Chi Michael

Chief Operating Officer

2 sales — total 4,804,131 USD

Planned sale 17 Mar 2026

Value US$2,402,065.41 | Price 24.69 | Shares 97,289

Proposed sale 17 Mar 2026

Value US$2,402,065.41 | Price 24.69 | Shares 97,289

Boughton Soleil

Chief Legal Officer

2 sales — total 141,483 USD

Planned sale 27 Feb 2026

Value US$70,741.71 | Price 15.21 | Shares 4,651

Proposed sale 27 Feb 2026

Value US$70,741.71 | Price 15.21 | Shares 4,651

Okupe Oluyemi

Chief Financial Officer

2 sales — total 278,216 USD

Sale 3 Feb 2026

Value US$139,107.81 | Price 26.44 | Shares 5,262

Sale 3 Feb 2026

Value US$139,107.81 | Price 26.44 | Shares 5,262

Okupe Oluyemi

Chief Financial Officer

1 sale — total 275,114 USD

Sale 20 Jan 2026

Value US$275,113.63 | Price 30.34 | Shares 9,067

Oluyemi Okupe

Officer

1 sale — total 828,906 USD

Proposed sale 20 Jan 2026

Value US$828,905.88 | Price 30.47 | Shares 27,204

Okupe Oluyemi

Chief Financial Officer

1 sale — total 306,453 USD

Planned sale 5 Jan 2026

Value US$306,452.62 | Price 33.79 | Shares 9,070

Okupe Oluyemi

Chief Financial Officer

1 sale — total 824,710 USD

Planned sale 22 Dec 2025

Value US$824,710.15 | Price 35.72 | Shares 23,090

Oluyemi Okupe

Officer

1 sale — total 1,127,208 USD

Proposed sale 22 Dec 2025

Value US$1,127,208.00 | Price 35.05 | Shares 32,160

Chi Michael

Chief Operating Officer

2 sales — total 1,009,525 USD

Planned sale 17 Dec 2025

Value US$504,762.50 | Price 36.71 | Shares 13,750

Proposed sale 17 Dec 2025

Value US$504,762.50 | Price 36.71 | Shares 13,750

Carroll Patrick Harrison

Chief Medical Officer

2 sales — total 735,742 USD

Planned sale 17 Dec 2025

Value US$367,870.91 | Price 36.71 | Shares 10,021

Proposed sale 17 Dec 2025

Value US$367,870.91 | Price 36.71 | Shares 10,021

Becklund Irene

PAO

2 sales — total 617,536 USD

Planned sale 17 Dec 2025

Value US$308,767.81 | Price 36.71 | Shares 8,411

Proposed sale 17 Dec 2025

Value US$308,767.81 | Price 36.71 | Shares 8,411

Autor Deborah M.

Chief Policy Officer

2 sales — total 517,905 USD

Planned sale 17 Dec 2025

Value US$258,952.34 | Price 36.71 | Shares 7,054

Proposed sale 17 Dec 2025

Value US$258,952.34 | Price 36.71 | Shares 7,054

Perez Garcia Andrea G

2 sales — total 195,850 USD

Sale 9 Dec 2025

Value US$97,925.00 | Price 39.17 | Shares 2,500

Proposed sale 9 Dec 2025

Value US$97,925.00 | Price 39.17 | Shares 2,500

Boughton Soleil

Chief Legal Officer

2 sales — total 185,038 USD

Planned sale 24 Nov 2025

Value US$92,663.82 | Price 35.22 | Shares 2,631

Proposed sale 24 Nov 2025

Value US$92,374.41 | Price 35.11 | Shares 2,631

Okupe Oluyemi

Chief Financial Officer

1 sale — total 853,490 USD

Planned sale 17 Nov 2025

Value US$853,490.28 | Price 36.81 | Shares 23,187

Boughton Soleil

Chief Legal Officer

2 sales — total 224,303 USD

Planned sale 10 Nov 2025

Value US$112,151.61 | Price 42.53 | Shares 2,637

Proposed sale 10 Nov 2025

Value US$112,151.61 | Price 42.53 | Shares 2,637

Boughton Soleil

Chief Legal Officer

2 sales — total 264,227 USD

Planned sale 27 Oct 2025

Value US$132,113.70 | Price 50.10 | Shares 2,637

Proposed sale 27 Oct 2025

Value US$132,113.70 | Price 50.10 | Shares 2,637

Okupe Oluyemi

Chief Financial Officer

1 sale — total 662,222 USD

Planned sale 17 Oct 2025

Value US$662,221.98 | Price 57.13 | Shares 11,592

Dudum Andrew

Chief Executive Officer

10 sales — total 22,059,997 USD

Planned sale 16 Oct 2025

Value US$1,044,969.23 | Price 62.70 | Shares 16,667

Planned sale 16 Oct 2025

Value US$148,009.35 | Price 63.39 | Shares 2,335

Planned sale 16 Oct 2025

Value US$2,466,112.47 | Price 62.70 | Shares 39,332

Planned sale 16 Oct 2025

Value US$664,626.56 | Price 63.49 | Shares 10,469

Planned sale 16 Oct 2025

Value US$2,478,803.21 | Price 62.71 | Shares 39,531

Planned sale 16 Oct 2025

Value US$1,065,792.69 | Price 62.69 | Shares 17,001

Planned sale 16 Oct 2025

Value US$534,513.47 | Price 63.46 | Shares 8,423

Planned sale 16 Oct 2025

Value US$2,452,247.97 | Price 62.70 | Shares 39,111

Planned sale 16 Oct 2025

Value US$174,923.83 | Price 62.65 | Shares 2,792

Proposed sale 16 Oct 2025

Value US$11,029,998.25 | Price 62.79 | Shares 175,661

Boughton Soleil

Officer

2 sales — total 286,800 USD

Proposed sale 13 Oct 2025

Value US$143,400.06 | Price 54.38 | Shares 2,637

Planned sale 13 Oct 2025

Value US$143,400.06 | Price 54.38 | Shares 2,637

Chi Michael

Chief Commercial Officer

2 sales — total 104,850 USD

Planned sale 10 Oct 2025

Value US$52,425.00 | Price 58.25 | Shares 900

Proposed sale 10 Oct 2025

Value US$52,425.00 | Price 58.25 | Shares 900

Okupe Oluyemi

Chief Financial Officer

1 sale — total 669,232 USD

Planned sale 3 Oct 2025

Value US$669,232.09 | Price 57.72 | Shares 11,595

Chi Michael

Chief Commercial Officer

2 sales — total 28,000 USD

Planned sale 1 Oct 2025

Value US$14,000.00 | Price 56.00 | Shares 250

Proposed sale 1 Oct 2025

Value US$14,000.00 | Price 56.00 | Shares 250

Okupe Oluyemi

Chief Financial Officer

1 sale — total 5,116,924 USD

Planned sale 29 Sep 2025

Value US$5,116,923.50 | Price 60.20 | Shares 85,000

Boughton Soleil

Chief Legal Officer

2 sales — total 310,058 USD

Planned sale 29 Sep 2025

Value US$155,029.23 | Price 58.79 | Shares 2,637

Proposed sale 29 Sep 2025

Value US$155,029.23 | Price 58.79 | Shares 2,637

Chi Michael

Chief Commercial Officer

1 sale — total 118,692 USD

Planned sale 24 Sep 2025

Value US$118,692.00 | Price 56.52 | Shares 2,100

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2026-06-23	2026-06-22	PlS Planned sale	3.3 Okupe Oluyemi Chief Financial Officer Officer	64,878 +4.1% 456.65 US$3,367,637	64,878 +4.1%	456.65	US$3,367,637
2026-06-23	2026-06-18	S Sale	3.5 Carroll Patrick Harrison Chief Medical Officer Officer	61,584 -25.5% 334.02 US$4,686,050	61,584 -25.5%	334.02	US$4,686,050
2026-06-18	2026-06-18	PrS Proposed sale	3.5 Carroll Patrick Harrison Officer Officer	74,926 279.52 US$3,561,118	74,926	279.52	US$3,561,118
2026-06-17	2026-06-17	PlS Planned sale	2.4 Becklund Irene PAO Officer	1,000 -39.8% 31.50 US$100,000	1,000 -39.8%	31.50	US$100,000
2026-06-17	2026-06-17	PlS Planned sale	0.5 Chi Michael Chief Operating Officer Officer	1,000 -3.1% 31.50 US$100,000	1,000 -3.1%	31.50	US$100,000
2026-06-17	2026-06-17	PlS Planned sale	Elshenawy Mohamed CTO Officer	1,000 -22.9% 31.50 US$100,000	1,000 -22.9%	31.50	US$100,000
2026-06-17	2026-06-17	PrS Proposed sale	2.4 Becklund Irene Officer Officer	1,000 31.50 US$100,000	1,000	31.50	US$100,000
2026-06-17	2026-06-17	PrS Proposed sale	Elshenawy Mohamed Officer Officer	1,000 31.50 US$100,000	1,000	31.50	US$100,000
2026-06-17	2026-06-17	PrS Proposed sale	0.5 Chi Michael Officer Officer	1,000 31.50 US$100,000	1,000	31.50	US$100,000
2026-06-17	2026-06-16	PlS Planned sale	2.4 Becklund Irene PAO Officer	1,000 -40.2% 30.25 US$100,000	1,000 -40.2%	30.25	US$100,000
2026-06-16	2026-06-16	PrS Proposed sale	2.4 Becklund Irene Officer Officer	1,000 30.25 US$100,000	1,000	30.25	US$100,000
2026-05-26	2026-05-26	B Purchase	2.6 WELLS DAVID B Non-Executive Director	48,400 +27.5% 24.24 US$1,172,974	48,400 +27.5%	24.24	US$1,172,974
2026-05-19	2026-05-18	PlS Planned sale	3.3 Okupe Oluyemi Chief Financial Officer Officer	7,950 -2.9% 23.64 US$187,916	7,950 -2.9%	23.64	US$187,916
2026-04-22	2026-04-20	PlS Planned sale	3.3 Boughton Soleil Chief Legal Officer Officer	9,463 -3.1% 30.00 US$283,890	9,463 -3.1%	30.00	US$283,890
2026-04-22	2026-04-20	PlS Planned sale	3.3 Okupe Oluyemi Chief Financial Officer Officer	19,645 -7.0% 29.96 US$588,615	19,645 -7.0%	29.96	US$588,615
2026-04-20	2026-04-20	PrS Proposed sale	3.3 Boughton Soleil Officer Officer	9,463 30.00 US$283,890	9,463	30.00	US$283,890
2026-04-20	2026-04-17	PlS Planned sale	3.3 Okupe Oluyemi Chief Financial Officer Officer	18,005 -6.3% 27.83 US$501,158	18,005 -6.3%	27.83	US$501,158
2026-04-20	2026-04-16	PlS Planned sale	3.3 Okupe Oluyemi Chief Financial Officer Officer	36,922 -11.6% 25.90 US$956,147	36,922 -11.6%	25.90	US$956,147
2026-04-07	2026-04-06	PlS Planned sale	3.3 Okupe Oluyemi Chief Financial Officer Officer	3,975 -1.2% 19.98 US$79,409	3,975 -1.2%	19.98	US$79,409
2026-04-06	2026-04-06	PrS Proposed sale	3.3 Oluyemi Okupe Officer Officer	240,560 20.33 US$4,890,585	240,560	20.33	US$4,890,585
2026-03-24	2026-03-20	PlS Planned sale	3.3 Okupe Oluyemi Chief Financial Officer Officer	9,217 -2.8% 23.77 US$219,067	9,217 -2.8%	23.77	US$219,067
2026-03-18	2026-03-17	PlS Planned sale	3.3 Boughton Soleil Chief Legal Officer Officer	4,812 -1.5% 24.69 US$118,808	4,812 -1.5%	24.69	US$118,808
2026-03-18	2026-03-17	PlS Planned sale	2.4 Becklund Irene PAO Officer	5,529 -38.7% 24.69 US$136,511	5,529 -38.7%	24.69	US$136,511
2026-03-18	2026-03-17	PlS Planned sale	0.5 Chi Michael Chief Operating Officer Officer	97,289 -19.3% 24.69 US$2,402,065	97,289 -19.3%	24.69	US$2,402,065
2026-03-17	2026-03-17	PrS Proposed sale	3.3 Boughton Soleil Officer Officer	4,812 24.69 US$118,808	4,812	24.69	US$118,808
2026-03-17	2026-03-17	PrS Proposed sale	2.4 Becklund Irene Officer Officer	5,529 24.69 US$136,511	5,529	24.69	US$136,511
2026-03-17	2026-03-17	PrS Proposed sale	0.5 Chi Michael Officer Officer	97,289 24.69 US$2,402,065	97,289	24.69	US$2,402,065
2026-03-02	2026-02-27	PlS Planned sale	3.3 Boughton Soleil Chief Legal Officer Officer	4,651 -1.0% 15.21 US$70,742	4,651 -1.0%	15.21	US$70,742
2026-02-27	2026-02-27	PrS Proposed sale	3.3 Boughton Soleil Officer Officer	4,651 15.21 US$70,742	4,651	15.21	US$70,742
2026-02-04	2026-02-03	S Sale	3.3 Okupe Oluyemi Chief Financial Officer Officer	5,262 -5.4% 26.44 US$139,108	5,262 -5.4%	26.44	US$139,108
2026-02-04	2026-02-03	S Sale	3.3 Okupe Oluyemi Chief Financial Officer Officer	5,262 -5.4% 26.44 US$139,108	5,262 -5.4%	26.44	US$139,108
2026-01-21	2026-01-20	S Sale	3.3 Okupe Oluyemi Chief Financial Officer Officer	9,067 -9.0% 30.34 US$275,114	9,067 -9.0%	30.34	US$275,114
2026-01-20	2026-01-20	PrS Proposed sale	3.3 Oluyemi Okupe Officer Officer	27,204 30.47 US$828,906	27,204	30.47	US$828,906
2026-01-07	2026-01-05	PlS Planned sale	3.3 Okupe Oluyemi Chief Financial Officer Officer	9,070 -9.0% 33.79 US$306,453	9,070 -9.0%	33.79	US$306,453
2025-12-23	2025-12-22	PlS Planned sale	3.3 Okupe Oluyemi Chief Financial Officer Officer	23,090 -19.7% 35.72 US$824,710	23,090 -19.7%	35.72	US$824,710
2025-12-22	2025-12-22	PrS Proposed sale	3.3 Oluyemi Okupe Officer Officer	32,160 35.05 US$1,127,208	32,160	35.05	US$1,127,208
2025-12-18	2025-12-17	PlS Planned sale	0.5 Chi Michael Chief Operating Officer Officer	13,750 -4.3% 36.71 US$504,762	13,750 -4.3%	36.71	US$504,762
2025-12-18	2025-12-17	PlS Planned sale	3.5 Carroll Patrick Harrison Chief Medical Officer Executive Director	10,021 -5.6% 36.71 US$367,871	10,021 -5.6%	36.71	US$367,871
2025-12-18	2025-12-17	PlS Planned sale	2.4 Becklund Irene PAO Officer	8,411 -79.8% 36.71 US$308,768	8,411 -79.8%	36.71	US$308,768
2025-12-18	2025-12-17	PlS Planned sale	2.0 Autor Deborah M. Chief Policy Officer Executive Director	7,054 -53.3% 36.71 US$258,952	7,054 -53.3%	36.71	US$258,952
2025-12-17	2025-12-17	PrS Proposed sale	3.5 Carroll Patrick Harrison Officer; Director Executive Director	10,021 36.71 US$367,871	10,021	36.71	US$367,871
2025-12-17	2025-12-17	PrS Proposed sale	0.5 Chi Michael Officer Officer	13,750 36.71 US$504,762	13,750	36.71	US$504,762
2025-12-17	2025-12-17	PrS Proposed sale	2.4 Becklund Irene Officer Officer	8,411 36.71 US$308,768	8,411	36.71	US$308,768
2025-12-17	2025-12-17	PrS Proposed sale	2.0 Autor Deborah M. Officer; Director Executive Director	7,054 36.71 US$258,952	7,054	36.71	US$258,952
2025-12-10	2025-12-09	S Sale	3.3 Perez Garcia Andrea G Non-Executive Director	2,500 -3.0% 39.17 US$97,925	2,500 -3.0%	39.17	US$97,925
2025-12-09	2025-12-09	PrS Proposed sale	3.3 Perez Garcia Andrea G Director Non-Executive Director	2,500 39.17 US$97,925	2,500	39.17	US$97,925
2025-11-25	2025-11-24	PlS Planned sale	3.3 Boughton Soleil Chief Legal Officer Officer	2,631 -1.7% 35.22 US$92,664	2,631 -1.7%	35.22	US$92,664
2025-11-24	2025-11-24	PrS Proposed sale	3.3 Boughton Soleil Officer Officer	2,631 35.11 US$92,374	2,631	35.11	US$92,374
2025-11-19	2025-11-17	PlS Planned sale	3.3 Okupe Oluyemi Chief Financial Officer Officer	23,187 -24.8% 36.81 US$853,490	23,187 -24.8%	36.81	US$853,490
2025-11-12	2025-11-10	PlS Planned sale	3.3 Boughton Soleil Chief Legal Officer Officer	2,637 -1.7% 42.53 US$112,152	2,637 -1.7%	42.53	US$112,152
2025-11-10	2025-11-10	PrS Proposed sale	3.3 Boughton Soleil Officer Officer	2,637 42.53 US$112,152	2,637	42.53	US$112,152
2025-10-28	2025-10-27	PlS Planned sale	3.3 Boughton Soleil Chief Legal Officer Officer	2,637 -1.6% 50.10 US$132,114	2,637 -1.6%	50.10	US$132,114
2025-10-27	2025-10-27	PrS Proposed sale	3.3 Boughton Soleil Officer Officer	2,637 50.10 US$132,114	2,637	50.10	US$132,114
2025-10-20	2025-10-17	PlS Planned sale	3.3 Okupe Oluyemi Chief Financial Officer Officer	11,592 -14.2% 57.13 US$662,222	11,592 -14.2%	57.13	US$662,222
2025-10-20	2025-10-16	PlS Planned sale	3.4 Dudum Andrew Chief Executive Officer Executive Director Large shareholder	16,667 -15.3% 62.70 US$1,044,969	16,667 -15.3%	62.70	US$1,044,969
2025-10-20	2025-10-16	PlS Planned sale	3.4 Dudum Andrew Chief Executive Officer Executive Director Large shareholder	2,335 -2.1% 63.39 US$148,009	2,335 -2.1%	63.39	US$148,009
2025-10-20	2025-10-16	PlS Planned sale	3.4 Dudum Andrew Chief Executive Officer Executive Director Large shareholder	39,332 -26.1% 62.70 US$2,466,112	39,332 -26.1%	62.70	US$2,466,112
2025-10-20	2025-10-16	PlS Planned sale	3.4 Dudum Andrew Chief Executive Officer Executive Director Large shareholder	10,469 -6.5% 63.49 US$664,627	10,469 -6.5%	63.49	US$664,627
2025-10-20	2025-10-16	PlS Planned sale	3.4 Dudum Andrew Chief Executive Officer Executive Director Large shareholder	39,531 -19.7% 62.71 US$2,478,803	39,531 -19.7%	62.71	US$2,478,803
2025-10-20	2025-10-16	PlS Planned sale	3.4 Dudum Andrew Chief Executive Officer Executive Director Large shareholder	17,001 -15.5% 62.69 US$1,065,793	17,001 -15.5%	62.69	US$1,065,793
2025-10-20	2025-10-16	PlS Planned sale	3.4 Dudum Andrew Chief Executive Officer Executive Director Large shareholder	8,423 -15.1% 63.46 US$534,513	8,423 -15.1%	63.46	US$534,513
2025-10-20	2025-10-16	PlS Planned sale	3.4 Dudum Andrew Chief Executive Officer Executive Director Large shareholder	39,111 -41.1% 62.70 US$2,452,248	39,111 -41.1%	62.70	US$2,452,248
2025-10-20	2025-10-16	PlS Planned sale	3.4 Dudum Andrew Chief Executive Officer Executive Director Large shareholder	2,792 -2.9% 62.65 US$174,924	2,792 -2.9%	62.65	US$174,924
2025-10-16	2025-10-16	PrS Proposed sale	3.4 Dudum Andrew Officer; Director Executive Director	175,661 62.79 US$11,029,998	175,661	62.79	US$11,029,998
2025-10-14	2025-10-13	PrS Proposed sale	3.3 Boughton Soleil Officer Officer	2,637 54.38 US$143,400	2,637	54.38	US$143,400
2025-10-14	2025-10-13	PlS Planned sale	3.3 Boughton Soleil Chief Legal Officer Officer	2,637 -1.6% 54.38 US$143,400	2,637 -1.6%	54.38	US$143,400
2025-10-14	2025-10-10	PlS Planned sale	0.5 Chi Michael Chief Commercial Officer Officer	900 -0.3% 58.25 US$52,425	900 -0.3%	58.25	US$52,425
2025-10-10	2025-10-10	PrS Proposed sale	0.5 Chi Michael Officer Officer	900 58.25 US$52,425	900	58.25	US$52,425
2025-10-07	2025-10-03	PlS Planned sale	3.3 Okupe Oluyemi Chief Financial Officer Officer	11,595 -14.2% 57.72 US$669,232	11,595 -14.2%	57.72	US$669,232
2025-10-02	2025-10-01	PlS Planned sale	0.5 Chi Michael Chief Commercial Officer Officer	250 -0.1% 56.00 US$14,000	250 -0.1%	56.00	US$14,000
2025-10-01	2025-10-01	PrS Proposed sale	0.5 Chi Michael Officer Officer	250 56.00 US$14,000	250	56.00	US$14,000
2025-09-30	2025-09-29	PlS Planned sale	3.3 Okupe Oluyemi Chief Financial Officer Officer	85,000 -54.8% 60.20 US$5,116,924	85,000 -54.8%	60.20	US$5,116,924
2025-09-30	2025-09-29	PlS Planned sale	3.3 Boughton Soleil Chief Legal Officer Officer	2,637 -1.6% 58.79 US$155,029	2,637 -1.6%	58.79	US$155,029
2025-09-29	2025-09-29	PrS Proposed sale	3.3 Boughton Soleil Officer Officer	2,637 58.79 US$155,029	2,637	58.79	US$155,029
2025-09-25	2025-09-24	PlS Planned sale	0.5 Chi Michael Chief Commercial Officer Officer	2,100 -0.7% 56.52 US$118,692	2,100 -0.7%	56.52	US$118,692

Explore more

More insider trading research around Hims & Hers Health Inc

More insider trades in United States

Similar Healthcare companies with insider activity

More Pharmaceuticals & Medical Research companies with insider activity

More Pharmaceuticals companies with insider activity

Insider trading in North America